Evaluation of Mitral and Aortic Valvular Disease and Left Ventricular Dysfunction in a Lebanese Population: Retrospective Single-Center Experience

Vanessa Nader; Anthony Matta; Ronan Canitrot; Romain Itier; Pascale Salameh; Olivier Lairez; Meyer Elbaz; Michel Galinier; Rania Azar; Jerome Roncalli

doi:10.12659/MSM.928218

09 February 2021 : Clinical Research

Evaluation of Mitral and Aortic Valvular Disease and Left Ventricular Dysfunction in a Lebanese Population: Retrospective Single-Center Experience

Vanessa Nader^12ABCDEF, Anthony Matta^13ABDEF, Ronan Canitrot^1ADEF, Romain Itier^1DEF, Pascale Salameh^2ACF, Olivier Lairez^1EF, Meyer Elbaz^1AEF, Michel Galinier^1AEF, Rania Azar^2ADEF, Jerome Roncalli^1ADEF*

DOI: 10.12659/MSM.928218

Med Sci Monit 2021; 27:e928218

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Table 3 Multivariate logistic regression for each type of valvular heart disease and left ventricular dysfunction, with cardiovascular risk factors as independent variables.

		Sex	Age	Smoker	AH	DLP	DM
	OR		0.89	5.7	1.1	0.64	1.26
	95% CI		[0.77–1.03]	[4.7–6.9]	[0.89–1.37]	[0.28–1.4]	[0.86–1.85]
			0.137	<0.001	0.33	0.29	0.21
	OR		2.66	18	1.7	1.95	0.49
	95% CI		[2.01–3.3]	[11.5–28.2]	[1.3–2.3]	[1.2–3.2]	[0.3–0.8]
			<0.001	<0.001	<0.001	0.007	0.006
	OR		1.16	1.7	1.07	0.58	2.1
	95% CI		[1.03–1.3]	[1.4–1.9]	[0.88–1.3]	[0.42–0.81]	[1.5–2.9]
			0.01	<0.001	0.48	0.001	0.001
	OR		3.8	0.75	10.8	0.67	0.35
	95% CI		[1.9–7.7]	[0.29–2.02]	[3.9–29.3]	[0.18–2.42]	[0.09–1.27]
			0.001	0.59	<0.001	0.54	0.11
	OR		1.18	1.25	1.52	1.27	0.55
	95% CI		[1.05–1.34]	[1.07–1.47]	[1.25–1.85]	[0.92–1.74]	[0.39–0.76]
			0.005	<0.001	<0.001	0.14	0.044
	OR		1.25	5.4	1.5	0.94	0.8
	95% CI		[107–1.46]	[4.4–6.5]	[1.2–1.8]	[0.65–1.37]	[0.55–1.18]
			0.004	<0.001	<0.001	0.76	0.26
	OR	1.17	1.4	1.4	1.4	0.86	0.82
	95% CI	[1.04–1.33]	[1.26–1.6]	[1.2–1.6]	[1.1–1.7]	[0.63–2]	[0.59–1.15]
		0.009	<0.001	<0.001	0.001	0.38	0.25
	OR	0.48	1.35	0.9	1.01	1.2	0.573
	95% CI	[0.4–0.56]	[1.1–1.5]	[0.5–1.5]	[0.8–1.2]	[0.9–1.5]	[0.2–1.4]
		<0.001	<0.001	0.72	0.89	0.054	0.2
AH – arterial hypertension; AMVD – aorto-mitral valve disease; AVR – aortic valve regurgitation; AVS – aortic valve stenosis; CI –confidence interval; DD – diastolic dysfunction; DLP – dyslipidemia; DM – diabetes mellitus; MVR – mitral valve regurgitation; MVS – mitral valve stenosis; OR – odds ratio; SD – systolic dysfunction; TR – tricuspid regurgitation.

Back to the Article

Evaluation of Mitral and Aortic Valvular Disease and Left Ventricular Dysfunction in a Lebanese Population: Retrospective Single-Center Experience

Your Privacy